These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 16625242

  • 1. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
    Santel A, Aleku M, Keil O, Endruschat J, Esche V, Durieux B, Löffler K, Fechtner M, Röhl T, Fisch G, Dames S, Arnold W, Giese K, Klippel A, Kaufmann J.
    Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L, Bieth A, Pillaire MJ, Cazaux C, Hoffmann JS, Couderc B, Teissié J.
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [Abstract] [Full Text] [Related]

  • 6. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
    Pirollo KF, Rait A, Zhou Q, Hwang SH, Dagata JA, Zon G, Hogrefe RI, Palchik G, Chang EH.
    Cancer Res; 2007 Apr 01; 67(7):2938-43. PubMed ID: 17409398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A.
    J Biotechnol; 2006 Jun 25; 124(1):12-25. PubMed ID: 16413079
    [Abstract] [Full Text] [Related]

  • 9. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.
    Takahashi Y, Nishikawa M, Kobayashi N, Takakura Y.
    J Control Release; 2005 Jul 20; 105(3):332-43. PubMed ID: 15936841
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
    Herringson TP, Altin JG.
    J Control Release; 2009 Nov 03; 139(3):229-38. PubMed ID: 19595724
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
    He XW, Yu X, Liu T, Yu SY, Chen DJ.
    Chin Med J (Engl); 2008 Mar 05; 121(5):439-44. PubMed ID: 18364118
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer.
    Yano J, Hirabayashi K, Nakagawa S, Yamaguchi T, Nogawa M, Kashimori I, Naito H, Kitagawa H, Ishiyama K, Ohgi T, Irimura T.
    Clin Cancer Res; 2004 Nov 15; 10(22):7721-6. PubMed ID: 15570006
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D, Losert D, Wacheck V.
    Clin Sci (Lond); 2006 Jan 15; 110(1):47-58. PubMed ID: 16336204
    [Abstract] [Full Text] [Related]

  • 20. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
    Bisanz K, Yu J, Edlund M, Spohn B, Hung MC, Chung LW, Hsieh CL.
    Mol Ther; 2005 Oct 15; 12(4):634-43. PubMed ID: 16039164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.